Technical development

Xemed collaborates with local area Universities and research centers in technical development of its hyperpolarized noble gas production systems and its chest coil development.

  • UNH
    University of New Hampshire
    Durham, New Hampshire, US

MagniXene® Imaging Network

Xemed collaborates with academic hospitals and medical research centers on the development of MagniXene® imaging protocols that are relevant for disease management and drug development.

  • Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania, US
  • Washington University School of Medicine
    Washington University in St. Louis
    St. Louis, Missouri, US
    Thunder Bay Regional Health Research Institute
    Thunder Bay Regional Health Sciences Centre
    Thunder Bay, Ontario, Canada

Past Collaborators

  • Athinoula A. Martinos Center
    Massachusetts General Hospital
    Charlestown, Massachusetts, US
  • University of Virginia Health System
    University of Virginia Health System
    Charlottesville, Virginia, US
  • Robarts Imaging
    Robarts Research Institute
    University of Western Ontario
    London, Ontario, Canada

Drug development

Xemed welcomes participation from pharmaceutical companies in the development of MagniXene® biomarkers for FDA qualification as a Drug Development Tool, to be used in staging and phenotyping disease of subjects enrolled in clinical trials and/or for assessing pharmacological activity of putative therapies.

  • (Name withheld)